ArticleJournal of Cancer2017

PD-L1 is a Prognostic Biomarker in Resected NSCLC Patients with Moderate/high Smoking History and Elevated Serum SCCA Level.

Lianjing Cao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.